INVITRO ACTIVITY OF L-627 AGAINST ANAEROBIC-BACTERIA

被引:11
作者
NORD, CE [1 ]
LINDMARK, A [1 ]
PERSSON, I [1 ]
机构
[1] NATL BACTERIOL LAB,S-10521 STOCKHOLM,SWEDEN
关键词
D O I
10.1007/BF01989987
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of L-627 against 370 anaerobic bacterial strains including anaerobic cocci, Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, other Bacteroides spp. and fusobacteria was determined by the agar dilution method. This activity was compared with that of piperacillin, cefoxitin, imipenem, meropenem, clindamycin, metronidazole and chloramphenicol. L-627, imipenem, meropenem, clindamycin, metronidazole and chloramphenicol were the most active agents tested. L-627 had in vitro activity similar to that of the other carbapenems tested.
引用
收藏
页码:757 / 760
页数:4
相关论文
共 5 条
[1]  
DORNBUSCH K, 1979, SCANDINAVIAN J INFEC, V19, P17
[2]  
Holdman L. V., 1977, ANAEROBE LABORATORY, P1
[3]   INVITRO ACTIVITY OF LJC10,627, A NEW CARBAPENEM ANTIBIOTIC WITH HIGH-STABILITY TO DEHYDROPEPTIDASE-I [J].
UBUKATA, K ;
HIKIDA, M ;
YOSHIDA, M ;
NISHIKI, K ;
FURUKAWA, Y ;
TASHIRO, K ;
KONNO, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :994-1000
[4]   INVITRO ANTIBACTERIAL ACTIVITY AND BETA-LACTAMASE STABILITY OF THE NEW CARBAPENEM LJC10,627 [J].
YOSHIDA, M ;
MITSUHASHI, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (08) :625-629
[5]  
1990, NCCLS M11A2 NAT COMM